Grow® Pharma T21 Vanilla Ice #6 Medical Cannabis Flower • 🇬🇧 MedBud™ UK

 Warning: Clinic Releaf® are deliberately charging patients over MSRP for medication through a partner pharmacy, without making other pharmacies available to their patients.
All patients must be offered free choice in pharmacy without influence nor penalty to avoid non-compliant 'prescription direction' breaking GMC and BMA guidelines - risking prescribing clinician's licence to practice.

Back to Grow® Pharma or All Bud/Flower

Branded by:Grow® Pharma Produced/Cultivated by:SafriCanna
Packaging for Grow® Pharma T21 Vanilla Ice #6 Medical Cannabis Flower
Reprintable Medication QR Code:
QR Code Linking to Medication

Grow® Pharma T21 Vanilla Ice #6 Medical Cannabis Flower

Gamma-Irradiated | Cultivated & Packaged in Flag of South Africa South Africa | Produced by SafriCanna

Hybrid | 21% THC | <1% CBD
Prescription Note: Listed as an Indica Hybrid medication by product brand.

Availability: Specials (Critical) 

From: £5.50/g (£154/oz)

More familiar with imperial weights? (Henry, Quarter, Half)

Leafly LogoOriginal Cultivar: Vanilla Ice #6
Parents: Jet Fuel Gelato x Flo White

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Comparative Values)

Alpha-Pinene7.34%Pine/Sharp156℃
Beta-Pinene9.16%Pine/Herbal165℃
Myrcene9.41%Herbal/Musk166-168℃
Limonene33.66%Citrus/Sour177℃
Caryophyllene14.52%Pepper/Spice119℃
Linalool10.64%Floral/Spice198℃
Humulene6.93%Woody/Earthy107℃
Ocimene3.14%Herbal/Sweet174-175℃
Camphene2.39%Earthy/Foresty159-162℃
Geraniol2.81%Rose/Floral230℃

MedBud currently tracks 16 common terpenes, more will be added.

Dosing Look-Up Table (Estimated)

0.01/g2.1/mg THCTrace CBD
0.05/g10.5/mg THCTrace CBD
0.1/g21/mg THCTrace CBD
0.15/g31.5/mg THCTrace CBD
0.2/g42/mg THCTrace CBD
0.25/g52.5/mg THCTrace CBD
0.3/g63/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
United Kingdom Grow® Pharma
Designation
T21
Cultivar/Strain
Vanilla Ice #6
Classification
Hybrid
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
18.9-23.1%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
South Africa SafriCanna
Cultivated in
Flag of South Africa South Africa
Irradiation
Gamma-Irradiated
Imported by
United Kingdom IPS Pharma
Imported as
Schedule II: Finished Product
Packaged in
Flag of South Africa South Africa

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Specials (Critical)

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Product Description Video Reviews1 Patient Reviews

Further details to follow.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United Kingdom About Grow Group PLC

Grow® Pharma Logo

At Grow, we know there are millions of patients who can benefit from cannabis medicines. We aim to cater to as many patients as possible by having the best basket of a variety of high-quality cannabis medicines.

GROW® is a Biopharmaceutical company created back in 2017, focused solely on cannabis-based medicines. Operating in both a vertically integrated and partner model to ensure the optimal, broadest supply of truly differentiated cannabis medicines to really drive the best outcomes for patients.

We put patients at the heart of everything we do.

growgroupplc.com

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)